Mark Wang

Mark Wang

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2020 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
PBPedro K. Beredjiklian
Pedro K. Beredjiklian
MWMark Wang
Mark Wang
KLKevin Lutsky
Kevin Lutsky
AVAlexander Vaccaro
Alexander Vaccaro
MRMichael Rivlin
Michael Rivlin
➢ While 3-dimensional (3D) printing was developed in the 1980s, it has been adopted for medical applications more recently. ➢ There are several ways of creating a file that can be modeled and printed, including computer-aided design software, a 3D scanner, Digital Imaging and Communications in Medicine files, and online libraries. ➢ The types of printers used for medical applications include fused deposition modeling, stereolithography, selective laser sintering, and bioprinters. ➢ Orthopaedic applications include the generation of prosthetics and orthotics, intraoperative guides, patient-specific implants, and anatomic models for preoperative planning and education. ➢ The availability of 3D-printed anatomic models may enhance surgeons’ preoperative planning and improve orthopaedic education with the generation of anatomic models. ➢ Children with an amputation or congenital limb differences, especially in communities with limited resources, can benefit from the increased access and diminished cost of 3D-printed prostheses. ➢ The clinical benefits of 3D-printed, custom arthroplasty implants are yet to be determined.

27 April 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
JFJolanta Fertala
Jolanta Fertala
MWMark Wang
Mark Wang
MRMichael Rivlin
Michael Rivlin
PBPedro K. Beredjiklian
Pedro K. Beredjiklian
JAJoseph A. Abboud
Joseph A. Abboud
AFAndrzej Fertala
Andrzej Fertala
Excessive scar formation is a hallmark of localized and systemic fibrotic disorders. Despite extensive studies to define valid anti-fibrotic targets and develop effective therapeutics, progressive fibrosis remains a significant medical problem. Regardless of the injury type or location of wounded tissue, excessive production and accumulation of collagen-rich extracellular matrix is the common denominator of all fibrotic disorders. A long-standing dogma was that anti-fibrotic approaches should focus on overall intracellular processes that drive fibrotic scarring. Because of the poor outcomes of these approaches, scientific efforts now focus on regulating the extracellular components of fibrotic tissues. Crucial extracellular players include cellular receptors of matrix components, macromolecules that form the matrix architecture, auxiliary proteins that facilitate the formation of stiff scar tissue, matricellular proteins, and extracellular vesicles that modulate matrix homeostasis. This review summarizes studies targeting the extracellular aspects of fibrotic tissue synthesis, presents the rationale for these studies, and discusses the progress and limitations of current extracellular approaches to limit fibrotic healing.

29 September 2005 in Chemical Engineering & Technology
Verified
Journal Article
Closed access
PDF file
Qingjie GuoQingjie Guo
Qingjie Guo
MWMark Wang
Mark Wang
YLY. Li
Y. Li
CYChaohe Yang
Chaohe Yang

28 October 2021 in Cureus
Verified
Journal Article
Open access
HSHope E Skibicki
Hope E Skibicki
BKBrian M. Katt
Brian M. Katt
KLKevin Lutsky
Kevin Lutsky
MWMark Wang
Mark Wang
RMRichard McEntee
Richard McEntee
MRMichael Rivlin
Michael Rivlin
With significant advancement in the field of biomaterials, alternatives to conventional fiberglass casts such as customized three-dimensional (3D) orthotics have been developed. However, there is a scarcity of reported experience regarding 3D-printed orthoses. The purpose of this study was to compare radiographic outcomes and patient satisfaction with fractures treated with either conventional or 3D-printed casts. We included 23 limbs from 22 patients, who were aged between 8-18 years, and with a diagnosis of an acute nondisplaced wrist or forearm fracture. Patients were randomized into two groups: consisting of those treated with a 3D-printed orthosis and those with conventional fiberglass cast. Outcomes included X-ray alignment and healing, cast fit, the appearance of the skin, ease of care, and overall satisfaction. Of note, 10/11 (91%) in the 3D cast group healed in an excellent position, and 1/11 healed in an acceptable position. Also, 11/12 (92%) in the conventional cast group healed in an excellent position, and 1/12 healed in an acceptable position. Radiographically, 11/11 (100%) of the fractures in the 3D group and 11/12 (92%) in the conventional cast group were found to be fully healed. No differences were found in terms of skin irritation by a blinded hand therapist. Patients reported significant differences in skin irritation, comfort, satisfaction, and cast care favoring 3D casts (p<0.05). 3D orthoses offer a promising opportunity to improve patients’ experiences with upper extremity casting while also providing appropriate immobilization.

9 July 2019 in HAND
Verified
Journal Article
Closed access
PDF file
MOMichael Okoli
Michael Okoli
MSMatthew Silverman
Matthew Silverman
JAJack Abboudi
Jack Abboudi
CJChristopher Jones
Christopher Jones
WKWilliam Kirkpatrick
William Kirkpatrick
AIAsif M. Ilyas
Asif M. Ilyas
Background: Ulnar styloid fractures (USFs) are common concomitant injuries associated with distal radius fractures (DRFs). Recent studies have found conflicting evidence on whether these fractures treated or untreated effect pain and functional outcomes. The purpose of this study was to prospectively evaluate pain and function outcomes of consecutively untreated USFs in surgically repaired DRFs. The study hypothesis was that there would be no difference in outcomes whether an USF is present or not, with all cases left untreated. Methods: A prospective study at a single institution of consecutive DRF treated surgically with volar locked plating was undertaken. No patients underwent fixation of an USF if present. There were no treated USF that were excluded. Patients with associated ulnar neck and shaft fractures were excluded. Functional outcome measures were analyzed using the Quick Disabilities of the Arm, Shoulder, and Hand score (QDASH) and the Patient-Rated Wrist Evaluation (PRWE) scores. Outcome measures were collected at 3 months and 1 year postoperatively. Results: There was an incidence of 52.2% (n = 70/134) USF associated with surgically treated DRF. By location, there were 52.9% (n = 37/70) ulnar styloid tip fractures and 46.1% (33/70) ulnar styloid base. There were 75.7% of USF (53/70) still not healed by 1-year follow-up. When comparing patients with a DRF without an USF versus DRF with an associated USF at 12 months, there was no statistical difference in the QDASH score (6.7 vs 8.4, P = .47) or the PRWE total score (4.8 vs 7.5, P = .24). Similarly, subgroup analysis showed no statistical difference in QDASH or PRWE scores at final follow-up in united USF versus nonunited USF subjects (QDASH 14.2 vs 6.8, P = .112; PRWE 14.8 vs 5.4, P = .185). Conclusions: USFs are a common concomitant injury occurring in nearly half of DRFs treated surgically. Our prospective cohort analysis showed that neither the presence, type, nor bony union status of a concomitant USF has any significant effect on patient outcomes or reoperations at 1-year postoperatively. Our study confirms our hypothesis that USF of the tip and base should be left untreated.

12 December 2023 in Gels
Verified
Journal Article
Open access
PDF file
ASAndrzej Steplewski
Andrzej Steplewski
JFJolanta Fertala
Jolanta Fertala
LCLan Cheng
Lan Cheng
MWMark Wang
Mark Wang
MRMichael Rivlin
Michael Rivlin
AFAndrzej Fertala
Andrzej Fertala
Excessive posttraumatic scarring in orthopedic tissues, such as joint capsules, ligaments, tendons, muscles, and peripheral nerves, presents a significant medical problem, resulting in pain, restricted joint mobility, and impaired musculoskeletal function. Current treatments for excessive scarring are often ineffective and require the surgical removal of fibrotic tissue, which can aggravate the problem. The primary component of orthopedic scars is collagen I-rich fibrils. Our research team has developed a monoclonal anti-collagen antibody (ACA) that alleviates posttraumatic scarring by inhibiting collagen fibril formation. We previously established the safety and efficacy of ACA in a rabbit-based arthrofibrosis model. In this study, we evaluate the utility of a well-characterized thermoresponsive hydrogel (THG) as a delivery vehicle for ACA to injury sites. Crucial components of the hydrogel included N-isopropylacrylamide, poly(ethylene glycol) diacrylate, and hyaluronic acid. Our investigation focused on in vitro ACA release kinetics, stability, and activity. Additionally, we examined the antigen-binding characteristics of ACA post-release from the THG in an in vivo context. Our preliminary findings suggest that the THG construct exhibits promise as a delivery platform for antibody-based therapeutics to reduce excessive scarring in orthopedic tissues.